Bellevue Life Sciences Acquisition Corp. issued a $40,000 unsecured promissory note to board member Jun Chul Whang, which is payable by November 9, 2024, or upon raising additional funds or completing a business combination; $50,000 was also deposited in the trust account for extending the business combination deadline.